FDA revokes EUAs for two SARS-CoV-2 tests

Advertisements

FDA revokes EUAs for two SARS-CoV-2 tests
kpage_drupal
Jun 27, 2022

The Food and Drug Administration today announced it has revoked the emergency use authorizations for the Simoa Semi-Quantitative SARS-CoV-2 IgG Antibody Test and Simoa SARS-CoV-2 N Protein Antigen Test because no viable (non-expired) tests remain.
 

Headline
Advertisements
Shopping Cart
Generated by Feedzy
error: Content is protected !!
Share via
Copy link
Powered by Social Snap